Chenliang Zhou

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Crosstalk between YAP-TEAD and PPAR suppresses HIV-1 LTR transcription in vitro.

Crosstalk between YAP-TEAD and PPAR suppresses HIV-1 LTR transcription in vitro.

Journal: Biochemical pharmacology
Published: March 11, 2025

In-situ silver (Ag) clusters strengthed spatial separation of photogenerated charge-carriers for efficient photocatalytic tetracycline antibiotic purification.

In-situ silver (Ag) clusters strengthed spatial separation of photogenerated charge-carriers for efficient photocatalytic tetracycline antibiotic purification.

Journal: Environmental research
Published: December 02, 2024

Safety, reactogenicity, and immunogenicity of ZR-202-CoV and ZR-202a-CoV recombinant vaccines compared with ComirnatyⓇ: A randomized, observer-blind, controlled, phase 1 study.

Safety, reactogenicity, and immunogenicity of ZR-202-CoV and ZR-202a-CoV recombinant vaccines compared with ComirnatyⓇ: A randomized, observer-blind, controlled, phase 1 study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: May 14, 2024

Preparation of Yb-Sb co-doped Ti/SnO2 electrode for electrocatalytic degradation of sulfamethoxazole (SMX).

Preparation of Yb-Sb co-doped Ti/SnO2 electrode for electrocatalytic degradation of sulfamethoxazole (SMX).

Journal: Chemosphere
Published: March 23, 2023

Dopamine modified natural glucomannan as a highly efficient inhibitor for mild steel: Experimental and theoretical methods.

Dopamine modified natural glucomannan as a highly efficient inhibitor for mild steel: Experimental and theoretical methods.

Journal: International journal of biological macromolecules
Published: December 06, 2022

In-depth characterization of protein N-glycosylation for a COVID-19 variant-design vaccine spike protein.

In-depth characterization of protein N-glycosylation for a COVID-19 variant-design vaccine spike protein.

Journal: Analytical and bioanalytical chemistry
Published: October 07, 2022

A potent, broadly protective vaccine against SARS-CoV-2 variants of concern.

A potent, broadly protective vaccine against SARS-CoV-2 variants of concern.

Journal: NPJ vaccines
Published: March 04, 2022

Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.

Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.

Journal: Vaccine
Published: September 14, 2021

Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology.

Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology.

Journal: Vaccine
Published: February 13, 2021

Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Journal: Human vaccines & immunotherapeutics
Published: September 22, 2020

Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris.

Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris.

Journal: Human vaccines & immunotherapeutics
Published: August 13, 2019

A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b.

A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b.

Journal: Biochemical pharmacology
Published: January 29, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026